-
Charles Loius Alphonse Laveran discovers the malaria parasite in the blood of a patient during his time as a French army surgeon in Algeria
-
Camilo Golgi contributes to the study of malaria by identifying that there was more than one form of the disease. One had a tertian periodocity and one had a quartan periodocity.
-
Ronald Ross determined that malaria parasites were transmitted to humans through infected mosquitos
-
Malaria control activities (vector controls) are set up in affected regions of the United States
-
DDT used at the end of World War II for malaria control, demonstrated to be effective as it killed of malaria infected mosquitos.
-
Allied Scientists confirm that Chloroquine is an effective antimalarial drug
-
The United States are cleared of Malaria as a significant health problem
-
Malaria is eradicated in the US
-
Some malaria parasites discovered to have developed a resistance to Chloroquine
-
Financial constraints and reduced control measure see an increase of malaria 3-fold
-
DDTs harmful nature is recognised, resulting in its ban
-
Europe rids itself of the malaria disease
-
Antigen based diagnostic tests for malaria are developed
-
Mosquirix antimalarial vaccine is developed
-
The mefloquine antimalarial is approved for use.
-
Childhood mortality to malaria reduced by roughly 20-30% due to the use of antimalarial coated bednets
-
The World Health Organisation train volunteers to travel to Africa and administer antimalarials to various communities
-
985,000 malaria deaths worldwide
-
The Plasmodium falciparum parasite genome is sequenced
-
Increasing in global funding to fight malaria, AIDS and other diseases
-
Phase II trials determined to provide partial protection in some African nations.
-
Severe cases of malaria are combated through the antimalarial Artesunate
-
UN develop the worlds first Malaria Day in an attempt to close the gaps in coverage for malaria prevention.
-
Trials for the Phase III vaccine begin in Africa
-
781,000 malaria deaths worldwide
-
655,000 deaths worldwide
-
Mosquirix is licensed for use worldwide by the European Union
-
African nations are invited to test run the Mosquirix vaccine for children from the ages of 5-9 months